Skip to content
DataLookout
Menu

NCT05981183

Transcutaneous Auricular Vagus Nerve Stimulation Device in CKD Population

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved at least 2 years later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 8 versions: 6 with changes below, 2 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion pushed from Jan 7, 2026 to Jan 31, 2028
    • Eligibility criteria expanded, about 12 words
  2. Minor Start date: Oct 15, 2023 to Aug 9, 2023v7
  3. Notable Start date: Aug 7, 2023 to Oct 15, 2023v6
  4. Minor Primary and study completion dates: Aug 7, 2025 to Jan 7, 2026v5
  5. Notable Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v2
  6. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Heart Rate Variability (HRV) at Baseline
Timeframe: Day 1 (15 minutes prior to administration of intervention)
HRV at Post-Intervention
Timeframe: Day 1 (15 minutes Post-Intervention)

Secondary (7)

Percentage of Participants with at least a 20% change in HRV from baseline to post-intervention
Blood Pressure at Baseline
Blood Pressure at Post-Intervention
Spontaneous Baroreceptor Sensitivity (BRS) at Baseline
Spontaneous BRS at Post-Intervention
Show 2 moreShow less
Heart Rate at Baseline
Heart Rate at Post-Intervention

Arms and interventions

Intervention AExperimental

Participants will receive 15 minutes of taVNS after an initial 15 minute rest-period and a 15 minute baseline measurement period. For participants assigned to Intervention A, the pulse width = 250 μs, and frequency = 50 Hz.

Intervention BExperimental

Participants will receive 15 minutes of taVNS after an initial 15 minute rest-period and a 15 minute baseline measurement period. For participants assigned to Intervention B, the pulse width = 300 μs, frequency = 25 Hz.

Devices: Transcutaneous electrical nerve stimulation unit (TENS)

Sites

1 site in 1 country

  • NYU Langone HealthNew York, New York, United States